 |
PDBsum entry 2gu8
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein,transferase/inhibitor
|
PDB id
|
|
|
|
2gu8
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chain A:
E.C.2.7.11.11
- cAMP-dependent protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Bioorg Med Chem Lett
16:4163-4168
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Discovery of 2-pyrimidyl-5-amidothiophenes as potent inhibitors for AKT: synthesis and SAR studies.
|
|
X.Lin,
J.M.Murray,
A.C.Rico,
M.X.Wang,
D.T.Chu,
Y.Zhou,
M.Del Rosario,
S.Kaufman,
S.Ma,
E.Fang,
K.Crawford,
A.B.Jefferson.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
A series of 2-pyrimidyl-5-amidothiophenes has been synthesized and evaluated for
AKT inhibition. SAR studies resulted in potent inhibitors of AKT with IC(50)
values as low as single digit nanomolar as represented by compound 2aa. Compound
2aa showed cellular activity including antiproliferation and downstream target
modulation. Selectivity profile is described. A co-crystal of 2aa with PKA is
determined and discussed.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
T.McHardy,
J.J.Caldwell,
K.M.Cheung,
L.J.Hunter,
K.Taylor,
M.Rowlands,
R.Ruddle,
A.Henley,
A.de Haven Brandon,
M.Valenti,
T.G.Davies,
L.Fazal,
L.Seavers,
F.I.Raynaud,
S.A.Eccles,
G.W.Aherne,
M.D.Garrett,
and
I.Collins
(2010).
Discovery of 4-amino-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamides as selective, orally active inhibitors of protein kinase B (Akt).
|
| |
J Med Chem,
53,
2239-2249.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
G.T.Lountos,
J.E.Tropea,
D.Zhang,
A.G.Jobson,
Y.Pommier,
R.H.Shoemaker,
and
D.S.Waugh
(2009).
Crystal structure of checkpoint kinase 2 in complex with NSC 109555, a potent and selective inhibitor.
|
| |
Protein Sci,
18,
92.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.A.Smyth,
and
I.Collins
(2009).
Measuring and interpreting the selectivity of protein kinase inhibitors.
|
| |
J Chem Biol,
2,
131-151.
|
 |
|
|
|
|
 |
J.P.Gustin,
D.P.Cosgrove,
and
B.H.Park
(2008).
The PIK3CA gene as a mutated target for cancer therapy.
|
| |
Curr Cancer Drug Targets,
8,
733-740.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |
|